Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Researchers find 'missing' genetic risk in cancer

A new study could help to answer an important riddle in our understanding of genetics: why research to look for the genetic causes of common diseases has failed to explain more than a fraction of the heritable risk of developing them.

14 Feb 2014

Researchers offer new options for men whose prostate cancer has spread to bones

Dartmouth-Hitchcock Norris Cotton Cancer Center has treated three men with a recently FDA-approved treatment, which offers new options for men whose prostate cancer has spread to their bones.

13 Feb 2014

Understanding genetic changes associated with aggressive prostate cancer

Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.

12 Feb 2014

Mayo Clinic researchers shed light on new mechanism by which prostate cancer develops in men

Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor - the cellular component that binds to male hormones.

11 Feb 2014

New combination MRI-ultrasound imaging system improves treatment for prostate cancer patients

A new combination MRI-ultrasound imaging system can result in fewer biopsies and better treatment decisions for prostate cancer patients.

10 Feb 2014

Immunology professor receives 2014 Szent-Györgyi Prize for progress in cancer research from NFCR

Discovering key elements of immune system T cell biology and applying that knowledge to create a new way to treat cancer has earned Jim Allison, Ph.D., the 2014 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.

10 Feb 2014

Ipsen’s phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

10 Feb 2014

Findings could open door to development of new therapies for treatment of prostate cancer

SCIENTISTS at the University of York have discovered how the prostate gland develops for the first time, according to research published today (Thursday, February 6) in Stem Cell Reports.

7 Feb 2014

Scientists engineered microchip coated with blood vessel cells to study cardiovascular nanomedicine

Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease.

5 Feb 2014

Invasive 3D mapping biopsies detect ultrasound-guided biopsies miss prostate cancers

Ultrasound-guided biopsies miss prostate cancers that are detected by the slightly more expensive and slightly more invasive 3D mapping biopsies. For example, in a 2006 study of 180 men diagnosed with early stage prostate cancer via ultrasound-guided biopsy, nearly a quarter were upgraded to a more clinically significant stage of disease after 3D mapping biopsy found pockets of cancer the first technique had missed.

5 Feb 2014

Research: SSeCKS/AKAP12 gene key inhibitor of prostate cancer metastasis

New evidence reported by researchers at Roswell Park Cancer Institute (RPCI) lends support to the hypothesis that the SSeCKS/AKAP12 gene is a key inhibitor of prostate cancer metastasis.

4 Feb 2014

Dormant prostate cancer cells in bone tissue can be reawakened, say researchers

Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of the body. Understanding this mechanism of action may allow researchers to intervene prior to disease progression.

31 Jan 2014

Chesapeake Urology for Kids introduced for pediatric care

Chesapeake Urology Associates, PA, the premier urology practice in Maryland and the Mid-Atlantic region, introduces Chesapeake Urology for Kids, a comprehensive program to treat urologic conditions in children from pre-natal to 18 years of age. This new division is being led by Robert Mevorach, MD, a fellowship trained pediatric urologist. An office exclusively for pediatric patients is now open at 25 Crossroads Drive in Owings Mills, Maryland.

31 Jan 2014

American Cancer Society, SU2C partner to fight against cancer

The American Cancer Society, the largest voluntary health organization in the world dedicated to eliminating cancer, and Stand Up To Cancer, the charitable initiative supporting groundbreaking research aimed at getting new treatments to patients in an accelerated timeframe, announced today an historic collaboration in the fight against cancer, which takes more than 585,000 lives in the U.S. each year and nearly 8 million worldwide.

30 Jan 2014

New pre-clinical data shows potential protective effects of GFT505 in different types of cancer

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.

30 Jan 2014

Study: Combination treatment more than halves mortality rates for prostate cancer

Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.

30 Jan 2014

Bladder, lung cancers are marked by shared differences in genetics that control cell cycle

A University of Colorado Cancer Center study published in the journal PLoS ONE shows that bladder and lung cancers are marked by shared differences in the genetics that control the cell cycle.

30 Jan 2014

Sen. Coburn pays out-of-pocket to see cancer doctor

Sen. Tom Coburn, R-Okla., who is undergoing treatment for prostate cancer, says the new insurance plan he purchased under the health law doesn't include his longstanding oncologist. He says he is paying out of pocket to see that doctor and is "doing well from a health standpoint."

30 Jan 2014

Dormant prostate cancer cells within bone tissue can be reawakened to a cancerous state

Dormant prostate cancer cells in bone tissue can be reawakened to cause secondary tumours, according to new research published in Endocrine-Related Cancer. Targeting the wake-up call could prevent metastasis and improve prostate cancer survival rates.

29 Jan 2014

Myriad Genetics' Prolaris opens door to a new era of personalized treatment for prostate cancer

Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.

29 Jan 2014

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Researchers find 'missing' genetic risk in cancer

Researchers offer new options for men whose prostate cancer has spread to bones

Understanding genetic changes associated with aggressive prostate cancer

Mayo Clinic researchers shed light on new mechanism by which prostate cancer develops in men

New combination MRI-ultrasound imaging system improves treatment for prostate cancer patients

Immunology professor receives 2014 Szent-Györgyi Prize for progress in cancer research from NFCR

Ipsen’s phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Findings could open door to development of new therapies for treatment of prostate cancer

Scientists engineered microchip coated with blood vessel cells to study cardiovascular nanomedicine

Invasive 3D mapping biopsies detect ultrasound-guided biopsies miss prostate cancers

Research: SSeCKS/AKAP12 gene key inhibitor of prostate cancer metastasis

Dormant prostate cancer cells in bone tissue can be reawakened, say researchers

Chesapeake Urology for Kids introduced for pediatric care

American Cancer Society, SU2C partner to fight against cancer

New pre-clinical data shows potential protective effects of GFT505 in different types of cancer

Study: Combination treatment more than halves mortality rates for prostate cancer

Bladder, lung cancers are marked by shared differences in genetics that control cell cycle

Sen. Coburn pays out-of-pocket to see cancer doctor

Dormant prostate cancer cells within bone tissue can be reawakened to a cancerous state

Myriad Genetics' Prolaris opens door to a new era of personalized treatment for prostate cancer

What to know about prostate cancer eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in